Diabetes Clinical Trial
Official title:
Effect of Intact vs. Highly Processed Whole Grains on Insulin Sensitivity and Other Cardiometabolic Risk Factors in Hyperinsulinemic Adults
Verified date | April 2017 |
Source | Boston Children’s Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary objective of this pilot study will be to examine the effects of consuming whole grains, differing in the degree of processing, on insulin sensitivity and other cardiometabolic risk factors. The overall aim will be to assess feasibility of the test diets and to generate preliminary data.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: - Aged 18 to 35 years - Body mass index = 25 and <40 kg/m2 - Serum fasting insulin >10 uIU/mL and one of the following metabolic syndrome components: waist circumference, men: =102 cm, women: =88 cm; triglycerides, =150 mg/dL; HDL-C, men: <40 mg/dL , women: <50 mg/dL; systolic blood pressure =130 or diastolic blood pressure =85 mmHg; or fasting glucose, =100 mg/dL - Medical clearance from a primary care provider to rule out any major medical illness, disability, or disorder (e.g., liver disease, renal failure, cancer) - Access to a working telephone or cell phone - Willingness to eat the grain foods provided during participation - If female, regular menstrual cycles (defined as 26-30 days, ±1 day full flow, i.e. 26 to 30 days between cycles; no more than one day variation in the duration of menstrual flow) Exclusion Criteria: - Pre-existing major medical illness by medical history or laboratory screening tests - Allergy or sensitivity to gluten (self-reported or physician diagnosed) - >5% change in weight within previous 6 months - Current smoking (1 cigarette in the past week) - Major surgery within the previous 6 months - Physical, mental, or cognitive handicaps that prevent participation. - Alcohol intake >7 drinks per week - Use of medications that may affect study outcomes - Use of antibiotics within the previous 3 months (in those who agree to complete the analyses of gut microbiome and fecal short chain fatty acids) - Use of illegal drugs - Plans to be away from home for 1 week or longer during the study period (e.g., vacation, relocation) - Another member of the family (first degree relative) or household participating in the study - If female, pregnancy or lactation during prior 12 months, plans to become pregnant during the study period, change in oral contraceptives within 3 months, or irregular menstrual cycle frequency (<10 bleeds/year) |
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital Boston | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Boston Children’s Hospital | Kansas State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from week 0 in peripheral insulin sensitivity (assessed by frequently-sampled oral glucose tolerance test) at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Primary | Change from week 0 in peripheral insulin sensitivity (assessed by frequently-sampled oral glucose tolerance test) at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Primary | Change from week 0 in peripheral insulin sensitivity (assessed by frequently-sampled oral glucose tolerance test) at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in hepatic insulin sensitivity (assessed by frequently-sampled oral glucose tolerance test) at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in hepatic insulin sensitivity (assessed by frequently-sampled oral glucose tolerance test) at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in hepatic insulin sensitivity (assessed by frequently-sampled oral glucose tolerance test) at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in fasting glucose at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in fasting glucose at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in fasting glucose at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in fasting insulin at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in fasting insulin at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in fasting insulin at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in blood lipids at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in blood lipids at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in blood lipids at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in high-sensitivity C-reactive protein at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in high-sensitivity C-reactive protein at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in high-sensitivity C-reactive protein at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in plasminogen activator inhibitor-1 (PAI-1) at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in plasminogen activator inhibitor-1 (PAI-1) at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in plasminogen activator inhibitor-1 (PAI-1) at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in alanine aminotransferase (ALT) at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in alanine aminotransferase (ALT) at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in alanine aminotransferase (ALT) at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in serum metabolomics profile at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in serum metabolomics profile at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in serum metabolomics profile at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in blood pressure at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in blood pressure at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in blood pressure at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in waist circumference at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in waist circumference at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in waist circumference at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in arterial stiffness (assessed by carotid-femoral pulse wave velocity) at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in arterial stiffness (assessed by carotid-femoral pulse wave velocity) at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in arterial stiffness (assessed by carotid-femoral pulse wave velocity) at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in gut microbiome composition (16s rRNA sequencing) and fecal short chain fatty acids at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in gut microbiome composition (16s rRNA sequencing) and fecal short chain fatty acids at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in gut microbiome composition (16s rRNA sequencing) and fecal short chain fatty acids at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in ratings of hunger and satiation at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in ratings of hunger and satiation at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in ratings of hunger and satiation at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in ratings of palatability and acceptability (gastrointestinal symptoms) at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in ratings of palatability and acceptability (gastrointestinal symptoms) at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in ratings of palatability and acceptability (gastrointestinal symptoms) at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in body weight at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in body weight at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in body weight at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in dietary intake at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in dietary intake at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in dietary intake at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in physical activity (assessed by accelerometry) at week 4 | Week 0, Week 4 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in physical activity (assessed by accelerometry) at week 8 | Week 0, Week 8 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) | ||
Secondary | Change from week 0 in physical activity (assessed by accelerometry) at week 12 | Week 0, Week 12 (End of 4-week diet of intact/minimally processed whole grains OR highly processed whole grains OR refined grains) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |